ShahinLockmanMD
Infectious Disease • Boston, MAAssociate Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School
Are you Dr. Lockman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 70 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-5885
Summary
- Dr. Shahin Lockman, MD is an infectious disease specialist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Hospital and is an Associate Professor at Harvard Medical School.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1998 - 2001
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1996
Northwestern University The Feinberg School of MedicineClass of 1993
Certifications & Licensure
MA State Medical License 1995 - 2026- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Clinical Trials
- NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission Start of enrollment: 2006 Nov 01
- Botswana Pediatric Respiratory Disease and Bloodstream Infection Study Start of enrollment: 2001 Mar 01
- Safety of Cotrimoxazole in HIV- and HAART-exposed Infants Start of enrollment: 2009 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants.Denise L Jacobson, Krista S Crider, Patricia DeMarrais, Sean Brummel, Mindy Zhang
The Journal of Infectious Diseases. 2024-11-15 - Lipid and glucose profiles in pregnant women with HIV on tenofovir-based antiretroviral therapy.Ahizechukwu C Eke, Sean S Brummel, Muktar H Aliyu, Lynda Stranix-Chibanda, George U Eleje
Clinical Infectious Diseases. 2024-09-02 - 4 citationsWeight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and P...Risa M Hoffman, Sean Brummel, Lauren Ziemba, Lameck Chinula, Katie McCarthy
Clinical Infectious Diseases. 2024-06-14
Press Mentions
Global Vaccine Equity Is Within Reach if We Act NowSeptember 24th, 2021- Massachusetts Infectious Disease Doctors Say COVID-19 Booster Plan Is Too BroadAugust 19th, 2021
- Really Rapid Review — CROI 2021 VirtualMarch 14th, 2021
- Join now to see all
Grant Support
- Effects Of HIV And ARV Exposure On Child Health And Neurodevelopment In Botswana.National Institute Of Mental Health2009–2012
- Short Breastfeeding And Cotrimoxazole Among Hiv-Exposed Infants In BotswanaEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
- Maternal And Infant Health And Haart Outcomes In The Mashi Pmtct Study, BotswanaEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
- Health Of Hiv-Infected Mothers After PMTCT, BotswanaEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007
- Respiratory Diseases/Bsi StudyEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2004
